839 related articles for article (PubMed ID: 36105620)
1. Current Advances in Chitosan Nanoparticles Based Oral Drug Delivery for Colorectal Cancer Treatment.
Choukaife H; Seyam S; Alallam B; Doolaanea AA; Alfatama M
Int J Nanomedicine; 2022; 17():3933-3966. PubMed ID: 36105620
[TBL] [Abstract][Full Text] [Related]
2. Micelles as potential drug delivery systems for colorectal cancer treatment.
Fatfat Z; Fatfat M; Gali-Muhtasib H
World J Gastroenterol; 2022 Jul; 28(25):2867-2880. PubMed ID: 35978871
[TBL] [Abstract][Full Text] [Related]
3. Nano-Chitosan Particles in Anticancer Drug Delivery: An Up-to-Date Review.
Kamath PR; Sunil D
Mini Rev Med Chem; 2017; 17(15):1457-1487. PubMed ID: 28245780
[TBL] [Abstract][Full Text] [Related]
4. The Advances in Chitosan-based Drug Delivery Systems for Colorectal Cancer: A Narrative Review.
Ali DS; Othman HO; Anwer ET
Curr Pharm Biotechnol; 2023; 24(12):1554-1559. PubMed ID: 36733239
[TBL] [Abstract][Full Text] [Related]
5. Application of chitosan-based nanocarriers in tumor-targeted drug delivery.
Ghaz-Jahanian MA; Abbaspour-Aghdam F; Anarjan N; Berenjian A; Jafarizadeh-Malmiri H
Mol Biotechnol; 2015 Mar; 57(3):201-18. PubMed ID: 25385004
[TBL] [Abstract][Full Text] [Related]
6. Recent Advancements in Metallic Au- and Ag-Based Chitosan Nanocomposite Derivatives for Enhanced Anticancer Drug Delivery.
El-Meligy MA; Abd El-Monaem EM; Eltaweil AS; Mohy-Eldin MS; Ziora ZM; Heydari A; Omer AM
Molecules; 2024 May; 29(10):. PubMed ID: 38792255
[TBL] [Abstract][Full Text] [Related]
7. Hierarchical targeted hepatocyte mitochondrial multifunctional chitosan nanoparticles for anticancer drug delivery.
Chen Z; Zhang L; Song Y; He J; Wu L; Zhao C; Xiao Y; Li W; Cai B; Cheng H; Li W
Biomaterials; 2015 Jun; 52():240-50. PubMed ID: 25818430
[TBL] [Abstract][Full Text] [Related]
8. Functionalized FcRn-targeted nanosystems for oral drug delivery: A new approach to colorectal cancer treatment.
Hameedat F; Pizarroso NA; Teixeira N; Pinto S; Sarmento B
Eur J Pharm Sci; 2022 Sep; 176():106259. PubMed ID: 35842140
[TBL] [Abstract][Full Text] [Related]
9. Mitochondria-targeting folic acid-modified nanoplatform based on mesoporous carbon and a bioactive peptide for improved colorectal cancer treatment.
Wang J; Zhang L; Xin H; Guo Y; Zhu B; Su L; Wang S; Zeng J; Chen Q; Deng R; Wang Z; Wang J; Jin X; Gui S; Xu Y; Lu X
Acta Biomater; 2022 Oct; 152():453-472. PubMed ID: 36084923
[TBL] [Abstract][Full Text] [Related]
10. Application of chitosan modified nanocarriers in breast cancer.
Dubey SK; Bhatt T; Agrawal M; Saha RN; Saraf S; Saraf S; Alexander A
Int J Biol Macromol; 2022 Jan; 194():521-538. PubMed ID: 34822820
[TBL] [Abstract][Full Text] [Related]
11. Nano-strategies as Oral Drug Delivery Platforms for Treatment of Cancer: Challenges and Future Perspectives.
Quadir SS; Saharan V; Choudhary D; Harish ; Jain CP; Joshi G
AAPS PharmSciTech; 2022 May; 23(5):152. PubMed ID: 35606661
[TBL] [Abstract][Full Text] [Related]
12. Tumor targeting strategies for chitosan-based nanoparticles.
Zhang X; Yang X; Ji J; Liu A; Zhai G
Colloids Surf B Biointerfaces; 2016 Dec; 148():460-473. PubMed ID: 27665379
[TBL] [Abstract][Full Text] [Related]
13. Engineered nanoparticles for imaging and drug delivery in colorectal cancer.
Pavitra E; Dariya B; Srivani G; Kang SM; Alam A; Sudhir PR; Kamal MA; Raju GSR; Han YK; Lakkakula BVKS; Nagaraju GP; Huh YS
Semin Cancer Biol; 2021 Feb; 69():293-306. PubMed ID: 31260733
[TBL] [Abstract][Full Text] [Related]
14. Nano-Drug Delivery Systems Based on Different Targeting Mechanisms in the Targeted Therapy of Colorectal Cancer.
Wang K; Shen R; Meng T; Hu F; Yuan H
Molecules; 2022 May; 27(9):. PubMed ID: 35566331
[TBL] [Abstract][Full Text] [Related]
15. Advances and applications of chitosan-based nanomaterials as oral delivery carriers: A review.
Lang X; Wang T; Sun M; Chen X; Liu Y
Int J Biol Macromol; 2020 Jul; 154():433-445. PubMed ID: 32194103
[TBL] [Abstract][Full Text] [Related]
16. Chitosan-modified nanocarriers as carriers for anticancer drug delivery: Promises and hurdles.
Alhodieb FS; Barkat MA; Barkat HA; Hadi HA; Khan MI; Ashfaq F; Rahman MA; Hassan MZ; Alanezi AA
Int J Biol Macromol; 2022 Sep; 217():457-469. PubMed ID: 35798082
[TBL] [Abstract][Full Text] [Related]
17. Orally Administrable Therapeutic Nanoparticles for the Treatment of Colorectal Cancer.
Ying K; Bai B; Gao X; Xu Y; Wang H; Xie B
Front Bioeng Biotechnol; 2021; 9():670124. PubMed ID: 34307319
[TBL] [Abstract][Full Text] [Related]
18. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
19. Chitosan Nanoparticles as Oral Drug Carriers.
Guadarrama-Escobar OR; Serrano-Castañeda P; Anguiano-Almazán E; Vázquez-Durán A; Peña-Juárez MC; Vera-Graziano R; Morales-Florido MI; Rodriguez-Perez B; Rodriguez-Cruz IM; Miranda-Calderón JE; Escobar-Chávez JJ
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901719
[TBL] [Abstract][Full Text] [Related]
20. Chitosan nanopolymers: An overview of drug delivery against cancer.
Shanmuganathan R; Edison TNJI; LewisOscar F; Kumar P; Shanmugam S; Pugazhendhi A
Int J Biol Macromol; 2019 Jun; 130():727-736. PubMed ID: 30771392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
